CABA insider trading
Open-market stock trades by Cabaletta Bio (CABA) executives and directors: who bought or sold, how many shares, at what price and when.
CABA insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | Chang David J. | Chief Medical Officer | Buy | 8,800 | $2.26 | $19.89K |
| Jan 21, 2026 | Binder Gwendolyn | President, Science & Tech. | Buy | 11,312 | $2.19 | $24.76K |
| Jan 21, 2026 | Tomasello Shawn | director | Buy | 22,725 | $2.21 | $50.32K |
| Jan 21, 2026 | Gavel Steve | Chief Commercial Officer | Buy | 22,170 | $2.27 | $50.22K |
| Jan 21, 2026 | Bollard Catherine | director | Buy | 4,405 | $2.27 | $9.98K |
| Jan 21, 2026 | Nichtberger Steven | President & CEO | Buy | 45,000 | $2.24 | $100.78K |
| Jan 21, 2026 | Simon Mark | director | Buy | 11,061 | $2.28 | $25.26K |
| Jan 21, 2026 | Gerard Michael | General Counsel | Buy | 6,600 | $2.27 | $14.98K |
- CABA insiders bought $296.19K and sold $0.00 in open-market trades over their last 8 filings.
Updated 2026-11-10 04:45 UTC